Dietary habits and physical activity in first-episode psychosis patients treated in community services. Effect on early anthropometric and cardio-metabolic alterations.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
02 2020
Historique:
received: 16 07 2019
revised: 27 10 2019
accepted: 05 11 2019
pubmed: 7 12 2019
medline: 22 6 2021
entrez: 7 12 2019
Statut: ppublish

Résumé

People with psychosis often develop metabolic and cardiovascular disorders, due to several factors including unhealthy lifestyle and antipsychotic treatment. This study aims to evaluate in a sample of first episode psychosis (FEP) patients lifestyle factors, with a specific emphasis on dietary habits and physical activity, and cardio-metabolic and anthropometric profile at illness onset and at 9 months. Moreover, this study aims to evaluate the impact of lifestyle factors on short term changes in cardio-metabolic and anthropometric profile. A 9-month follow-up study was conducted on a sample of 96 FEP patients recruited within the context of the GET UP program. Standardised assessments of dietary habits (EPIC) and physical activity (IPAQ) were retrospectively performed at 9 months; cardiovascular measures (blood pressure, heart rate), metabolic parameters (glucose, cholesterol, triglycerides), BMI and antipsychotic treatment were assessed at illness onset and at 9 months. We found that most FEP patients (60%) displayed poor dietary habits, as defined in terms of adherence to the Mediterranean diet. A significant increase for both BMI and cholesterol levels was found in the overall sample over 9 months. However, when considering the effect of lifestyle factors, BMI and total cholesterol were specifically raised in patients with low adherence to Mediterranean diet. The association with antipsychotic medication was found for SGA only, with a significant increase in both BMI and total cholesterol overtime. Our findings confirm the need to implement specific and early strategies to promote healthy lifestyle in people with FEP, since metabolic alterations occur within the first months of treatment.

Identifiants

pubmed: 31806524
pii: S0920-9964(19)30508-0
doi: 10.1016/j.schres.2019.11.010
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-381

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Elena Saugo (E)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Antonio Lasalvia (A)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy; UOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI) di Verona, Italy. Electronic address: antonio.lasalvia@univr.it.

Chiara Bonetto (C)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Doriana Cristofalo (D)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Sara Poli (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Sarah Bissoli (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Mariaelena Bertani (M)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Lorenza Lazzarotto (L)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Francesco Gardellin (F)

Dipartimento di Salute Mentale, Azienda ULSS 8 Berica, Vicenza, Italy.

Enrico Ceccato (E)

Dipartimento di Salute Mentale, Azienda ULSS 8 Berica, Vicenza, Italy.

Michele Pavanati (M)

Dipartimento di Salute Mentale e Dipendenze Patologiche, AUSL Ferrara, Italy.

Sarah Tosato (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy; UOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI) di Verona, Italy.

Mirella Ruggeri (M)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy; UOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI) di Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH